vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and TEXAS CAPITAL BANCSHARES INC (TCBI). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $324.0M, roughly 1.1× TEXAS CAPITAL BANCSHARES INC). TEXAS CAPITAL BANCSHARES INC runs the higher net margin — 22.8% vs -0.8%, a 23.6% gap on every dollar of revenue. On growth, TEXAS CAPITAL BANCSHARES INC posted the faster year-over-year revenue change (15.5% vs 9.4%). Over the past eight quarters, TEXAS CAPITAL BANCSHARES INC's revenue compounded faster (10.2% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
Texas Capital Bank is a bank headquartered in Dallas, Texas. The bank has branches located in every major city in Texas. Its parent bank holding company is Texas Capital Bancshares. It also operates an online-only banking division, Bask Bank.
ASIX vs TCBI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $324.0M |
| Net Profit | $-2.8M | $73.8M |
| Gross Margin | 7.6% | — |
| Operating Margin | -0.7% | — |
| Net Margin | -0.8% | 22.8% |
| Revenue YoY | 9.4% | 15.5% |
| Net Profit YoY | -892.9% | 56.8% |
| EPS (diluted) | $-0.11 | $1.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $324.0M | ||
| Q4 25 | $359.9M | $327.5M | ||
| Q3 25 | $374.5M | $340.4M | ||
| Q2 25 | $410.0M | $307.5M | ||
| Q1 25 | $377.8M | $280.5M | ||
| Q4 24 | $329.1M | $229.6M | ||
| Q3 24 | $398.2M | $125.3M | ||
| Q2 24 | $453.5M | $267.0M |
| Q1 26 | — | $73.8M | ||
| Q4 25 | $-2.8M | $100.7M | ||
| Q3 25 | $-2.6M | $105.2M | ||
| Q2 25 | $31.4M | $77.3M | ||
| Q1 25 | $23.3M | $47.0M | ||
| Q4 24 | $352.0K | $71.0M | ||
| Q3 24 | $22.3M | $-61.3M | ||
| Q2 24 | $38.9M | $41.7M |
| Q1 26 | — | — | ||
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 14.3% | — | ||
| Q1 25 | 14.2% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 17.9% | — |
| Q1 26 | — | — | ||
| Q4 25 | -0.7% | 40.4% | ||
| Q3 25 | -0.9% | 40.5% | ||
| Q2 25 | 7.7% | 33.2% | ||
| Q1 25 | 7.7% | 21.6% | ||
| Q4 24 | -3.9% | 40.7% | ||
| Q3 24 | 7.5% | -63.8% | ||
| Q2 24 | 11.5% | 21.9% |
| Q1 26 | — | 22.8% | ||
| Q4 25 | -0.8% | 30.7% | ||
| Q3 25 | -0.7% | 30.9% | ||
| Q2 25 | 7.7% | 25.2% | ||
| Q1 25 | 6.2% | 16.8% | ||
| Q4 24 | 0.1% | 30.9% | ||
| Q3 24 | 5.6% | -48.9% | ||
| Q2 24 | 8.6% | 15.6% |
| Q1 26 | — | $1.56 | ||
| Q4 25 | $-0.11 | $2.11 | ||
| Q3 25 | $-0.10 | $2.18 | ||
| Q2 25 | $1.15 | $1.58 | ||
| Q1 25 | $0.86 | $0.92 | ||
| Q4 24 | $0.02 | $1.43 | ||
| Q3 24 | $0.82 | $-1.41 | ||
| Q2 24 | $1.43 | $0.80 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | — |
| Total DebtLower is stronger | — | $878.3M |
| Stockholders' EquityBook value | $815.2M | $3.6B |
| Total Assets | $1.7B | $33.5B |
| Debt / EquityLower = less leverage | — | 0.24× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $19.8M | — | ||
| Q3 25 | $23.7M | — | ||
| Q2 25 | $18.4M | — | ||
| Q1 25 | $8.3M | — | ||
| Q4 24 | $19.6M | — | ||
| Q3 24 | $17.3M | — | ||
| Q2 24 | $12.1M | — |
| Q1 26 | — | $878.3M | ||
| Q4 25 | — | $620.6M | ||
| Q3 25 | — | $620.4M | ||
| Q2 25 | — | $620.3M | ||
| Q1 25 | — | $660.5M | ||
| Q4 24 | — | $660.3M | ||
| Q3 24 | — | $660.2M | ||
| Q2 24 | — | $660.0M |
| Q1 26 | — | $3.6B | ||
| Q4 25 | $815.2M | $3.6B | ||
| Q3 25 | $818.2M | $3.6B | ||
| Q2 25 | $823.7M | $3.5B | ||
| Q1 25 | $794.4M | $3.4B | ||
| Q4 24 | $774.6M | $3.4B | ||
| Q3 24 | $766.4M | $3.4B | ||
| Q2 24 | $746.6M | $3.2B |
| Q1 26 | — | $33.5B | ||
| Q4 25 | $1.7B | $31.5B | ||
| Q3 25 | $1.7B | $32.5B | ||
| Q2 25 | $1.6B | $31.9B | ||
| Q1 25 | $1.6B | $31.4B | ||
| Q4 24 | $1.6B | $30.7B | ||
| Q3 24 | $1.5B | $31.6B | ||
| Q2 24 | $1.5B | $29.9B |
| Q1 26 | — | 0.24× | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.17× | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.19× | ||
| Q4 24 | — | 0.20× | ||
| Q3 24 | — | 0.20× | ||
| Q2 24 | — | 0.21× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | — |
| Free Cash FlowOCF − Capex | $36.1M | — |
| FCF MarginFCF / Revenue | 10.0% | — |
| Capex IntensityCapex / Revenue | 7.7% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $63.7M | $360.2M | ||
| Q3 25 | $26.6M | $166.3M | ||
| Q2 25 | $21.1M | $63.0M | ||
| Q1 25 | $11.4M | $368.0K | ||
| Q4 24 | $64.2M | $480.1M | ||
| Q3 24 | $57.3M | $332.8M | ||
| Q2 24 | $50.2M | $33.3M |
| Q1 26 | — | — | ||
| Q4 25 | $36.1M | $347.6M | ||
| Q3 25 | $66.0K | $161.3M | ||
| Q2 25 | $-7.2M | $57.5M | ||
| Q1 25 | $-22.6M | $-2.0M | ||
| Q4 24 | $29.8M | $415.2M | ||
| Q3 24 | $26.8M | $317.6M | ||
| Q2 24 | $16.7M | $11.1M |
| Q1 26 | — | — | ||
| Q4 25 | 10.0% | 106.1% | ||
| Q3 25 | 0.0% | 47.4% | ||
| Q2 25 | -1.7% | 18.7% | ||
| Q1 25 | -6.0% | -0.7% | ||
| Q4 24 | 9.1% | 180.9% | ||
| Q3 24 | 6.7% | 253.4% | ||
| Q2 24 | 3.7% | 4.1% |
| Q1 26 | — | — | ||
| Q4 25 | 7.7% | 3.8% | ||
| Q3 25 | 7.1% | 1.5% | ||
| Q2 25 | 6.9% | 1.8% | ||
| Q1 25 | 9.0% | 0.9% | ||
| Q4 24 | 10.4% | 28.2% | ||
| Q3 24 | 7.7% | 12.1% | ||
| Q2 24 | 7.4% | 8.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.58× | ||
| Q3 25 | — | 1.58× | ||
| Q2 25 | 0.67× | 0.81× | ||
| Q1 25 | 0.49× | 0.01× | ||
| Q4 24 | 182.29× | 6.76× | ||
| Q3 24 | 2.57× | — | ||
| Q2 24 | 1.29× | 0.80× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
TCBI
Segment breakdown not available.
